| Name | Title | Contact Details |
|---|---|---|
Lucas Donigian |
Vice President, Head of Business Development and Commercial | Profile |
Bijal Desai |
Vice President of Finance and Strategy | Profile |
Laura O`Connor |
Vice President of Human Resources and Diversity, Equity, and Inclusion | Profile |
Neil Klompas |
Chief Operating Officer and Chief Financial Officer | Profile |
Prem Girn |
Senior Director and Human Resources Business Partner | Profile |
Corventis is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Taueret Laboratories is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Uromedica, Inc. is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
MicroBiotix is a Worcester, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Metavention is a venture-backed medical device company founded in 2012 that is developing a novel glucose control therapy for patients with type 2 diabetes. Metabolic Neuromodulation Therapy (MNT) is a simple cardiovascular procedure intended to modulate sympathetic nervous system activity in patients with Type 2 diabetes for the purpose of lowering blood glucose levels. MNT was developed based on published scientific data and extensive animal studies suggesting a link between elevated sympathetic nerve activity in the metabolic system and increased levels of blood glucose. MNT is currently being studied in human clinical trials and represents a potentially important new treatment option for patients with Type 2 Diabetes.